<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03682913</url>
  </required_header>
  <id_info>
    <org_study_id>0105-18-HMO</org_study_id>
    <nct_id>NCT03682913</nct_id>
  </id_info>
  <brief_title>Personalized Inhibitory Control Training for Compulsive Behavior Change</brief_title>
  <official_title>Personalized Inhibitory Control Training for Compulsive Behavior Change</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hebrew University of Jerusalem</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hebrew University of Jerusalem</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obsessive-compulsive disorder (OCD) is a severe mental illness characterized by repetitive&#xD;
      behaviors that a person feels compelled to perform. It has been demonstrated that stimuli in&#xD;
      the environment can trigger the compulsive urge, perpetuating the OCD cycle. The main goal of&#xD;
      the current proposal, which is based on exciting pilot data, is to test a novel computerized&#xD;
      training program to create an association between OCD-related stimuli, which typically&#xD;
      trigger the compulsive urge, and the brain system responsible for stopping. The idea is that&#xD;
      once this system is triggered, it will be easier for patients to stop the compulsive urge.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Anticipated">August 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fMRI- changed inhibition levels in the pre-SMA area in experimental group in comparison to control group</measure>
    <time_frame>One week after P-CIT training starts</time_frame>
    <description>During tasks that require inhibition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fMRI- changed inhibition levels in the rIFG area in experimental group in comparison to control group</measure>
    <time_frame>One week after P-CIT training starts</time_frame>
    <description>During tasks that require inhibition</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Behavioural- Y-bocs (Yale-Brown Obsessive-Compulsive Scale) score- change in OCD symptoms in experimental group in comparison to placebo group</measure>
    <time_frame>One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training</time_frame>
    <description>Clinical assessment. Semi-structured interview that assesses the presence and severity of obsessions and compulsions over the past week. The 5-item Obsession Severity and Compulsion Severity subscales are summed to produce a Total Severity score. Symptoms endorsed are rated on a scale from none (0) to extreme (5). The 5-item Obsession Severity and Compulsion Severity subscales are summed to produce a Total Severity score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural- M.I.N.I (Mini-International Neuropsychiatric Interview) score- change in OCD symptoms in experimental group in comparison to placebo group</measure>
    <time_frame>One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training</time_frame>
    <description>Clinical assessment. Structural interview.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural- OCI-R (Obsessive-Compulsive Inventory) score- change in OCD symptoms in experimental group in comparison to placebo group</measure>
    <time_frame>One week after P-CIT (Personalized Inhibitory Control Training for Compulsive Behavior Change) training</time_frame>
    <description>Clinical assessment. Cutoff score of 21 is distinguish individuals with OCD from those without anxiety disorders.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>OCD</condition>
  <arm_group>
    <arm_group_label>P-CIT protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>OCD patients who receive the P-CIT intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>OCD patients who don't receive the P-CIT intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>P-CIT protocol</intervention_name>
    <description>Personalized inhibitory control training for one week.</description>
    <arm_group_label>P-CIT protocol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>without personalized inhibitory control training for one week.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  OCD patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Metal/ electronic device&#xD;
&#xD;
          -  Under the age of 18&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Tattoos that cover over 10% of body mass&#xD;
&#xD;
          -  Chronically ill patients&#xD;
&#xD;
          -  Psychosis/ Bi-polar&#xD;
&#xD;
          -  Substance abuse&#xD;
&#xD;
          -  Sever depression&#xD;
&#xD;
          -  Active suicide thoughts&#xD;
&#xD;
          -  Hearing loss&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shahaf Leshem, B.A.</last_name>
    <phone>0545455509</phone>
    <email>shahaf.leshem@mail.huji.ac.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Hebrew University of Jerusalem</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shahaf Leshem</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 23, 2018</study_first_submitted>
  <study_first_submitted_qc>September 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>September 25, 2018</last_update_submitted>
  <last_update_submitted_qc>September 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hebrew University of Jerusalem</investigator_affiliation>
    <investigator_full_name>Shahaf Leshem</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Behavior</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

